Literature DB >> 27218664

Cell-free microRNAs in blood and other body fluids, as cancer biomarkers.

Blanca Ortiz-Quintero1.   

Abstract

The discovery of cell-free microRNAs (miRNAs) in serum, plasma and other body fluids has yielded an invaluable potential source of non-invasive biomarkers for cancer and other non-malignant diseases. miRNAs in the blood and other body fluids are highly stable in biological samples and are resistant to environmental conditions, such as freezing, thawing or enzymatic degradation, which makes them convenient as potential biomarkers. In addition, they are more easily sampled than tissue miRNAs. Altered levels of cell-free miRNAs have been found in every type of cancer analysed, and increasing evidence indicates that they may participate in carcinogenesis by acting as cell-to-cell signalling molecules. This review summarizes the biological characteristics and mechanisms of release of cell-free miRNAs that make them promising candidates as non-invasive biomarkers of cancer.
© 2016 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27218664      PMCID: PMC6496612          DOI: 10.1111/cpr.12262

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  234 in total

1.  A microRNA cluster as a target of genomic amplification in malignant lymphoma.

Authors:  H Tagawa; M Seto
Journal:  Leukemia       Date:  2005-11       Impact factor: 11.528

2.  Identification of forensically relevant body fluids using a panel of differentially expressed microRNAs.

Authors:  Erin K Hanson; Helge Lubenow; Jack Ballantyne
Journal:  Anal Biochem       Date:  2009-02-03       Impact factor: 3.365

3.  Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma.

Authors:  Jian Zhou; Lei Yu; Xue Gao; Jie Hu; Jiping Wang; Zhi Dai; Jie-Fei Wang; Zhiyong Zhang; Shaohua Lu; Xiaowu Huang; Zheng Wang; Shuangjian Qiu; Xiaoying Wang; Guohuan Yang; Huichuan Sun; Zhaoyou Tang; Ying Wu; Hongguang Zhu; Jia Fan
Journal:  J Clin Oncol       Date:  2011-11-21       Impact factor: 44.544

4.  Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1.

Authors:  Mohd W Nasser; Jharna Datta; Gerard Nuovo; Huban Kutay; Tasneem Motiwala; Sarmila Majumder; Bo Wang; Saul Suster; Samson T Jacob; Kalpana Ghoshal
Journal:  J Biol Chem       Date:  2008-09-25       Impact factor: 5.157

5.  Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis.

Authors:  Yongxin Chen; Raymond L Stallings
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

6.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.

Authors:  Li Ma; Julie Teruya-Feldstein; Robert A Weinberg
Journal:  Nature       Date:  2007-09-26       Impact factor: 49.962

7.  Circulating microRNAs in esophageal squamous cell carcinoma: association with locoregional staging and survival.

Authors:  Bing-Xin Li; Qi Yu; Ze-Liang Shi; Ping Li; Shen Fu
Journal:  Int J Clin Exp Med       Date:  2015-05-15

8.  A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer.

Authors:  Fabrizio Bianchi; Francesco Nicassio; Matteo Marzi; Elena Belloni; Valentina Dall'olio; Loris Bernard; Giuseppe Pelosi; Patrick Maisonneuve; Giulia Veronesi; Pier Paolo Di Fiore
Journal:  EMBO Mol Med       Date:  2011-07-11       Impact factor: 12.137

9.  Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers.

Authors:  Johan Skog; Tom Würdinger; Sjoerd van Rijn; Dimphna H Meijer; Laura Gainche; Miguel Sena-Esteves; William T Curry; Bob S Carter; Anna M Krichevsky; Xandra O Breakefield
Journal:  Nat Cell Biol       Date:  2008-11-16       Impact factor: 28.824

10.  MiR-152 suppresses the proliferation and invasion of NSCLC cells by inhibiting FGF2.

Authors:  Zhenshun Cheng; Rongli Ma; Weijun Tan; Li Zhang
Journal:  Exp Mol Med       Date:  2014-09-05       Impact factor: 8.718

View more
  27 in total

1.  Oligonucleotide-Addressed Covalent 3'-Terminal Derivatization of Small RNA Strands for Enrichment and Visualization.

Authors:  Aleksandr Osipenko; Alexandra Plotnikova; Milda Nainytė; Viktoras Masevičius; Saulius Klimašauskas; Giedrius Vilkaitis
Journal:  Angew Chem Int Ed Engl       Date:  2017-05-04       Impact factor: 15.336

2.  MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies - a short report.

Authors:  Antonella Caivano; Francesco La Rocca; Vittorio Simeon; Marco Girasole; Simone Dinarelli; Ilaria Laurenzana; Angelo De Stradis; Luciana De Luca; Stefania Trino; Antonio Traficante; Giovanni D'Arena; Giovanna Mansueto; Oreste Villani; Giuseppe Pietrantuono; Luca Laurenti; Luigi Del Vecchio; Pellegrino Musto
Journal:  Cell Oncol (Dordr)       Date:  2016-10-19       Impact factor: 6.730

3.  MiR-22-3p suppresses cell growth via MET/STAT3 signaling in lung cancer.

Authors:  Xia Yang; Wenmei Su; Yu Li; Zhiqing Zhou; Yi Zhou; Hu Shan; Xiaoling Han; Ming Zhang; Qiuhong Zhang; Ying Bai; Chunfang Guo; Shuanying Yang; David G Beer; Guoan Chen
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

Review 4.  The potential of cell-free and exosomal microRNAs as biomarkers in liquid biopsy in patients with prostate cancer.

Authors:  Monyse de Nóbrega; Mariana Bisarro Dos Reis; Érica Romão Pereira; Marilesia Ferreira de Souza; Ilce Mara de Syllos Cólus
Journal:  J Cancer Res Clin Oncol       Date:  2022-08-04       Impact factor: 4.322

5.  Urinary Exosomal MicroRNAs as Potential Non-invasive Biomarkers in Breast Cancer Detection.

Authors:  Marc Hirschfeld; Gerta Rücker; Daniela Weiß; Kai Berner; Andrea Ritter; Markus Jäger; Thalia Erbes
Journal:  Mol Diagn Ther       Date:  2020-04       Impact factor: 4.074

6.  Differential expression of microRNAs and their possible roles in patients with chronic idiopathic urticaria and active hives.

Authors:  Ching-Kow E Lin; John S Kaptein; Javed Sheikh
Journal:  Allergy Rhinol (Providence)       Date:  2017-06-01

Review 7.  Secreted and Tissue miRNAs as Diagnosis Biomarkers of Malignant Pleural Mesothelioma.

Authors:  Vanessa Martínez-Rivera; María Cristina Negrete-García; Federico Ávila-Moreno; Blanca Ortiz-Quintero
Journal:  Int J Mol Sci       Date:  2018-02-17       Impact factor: 5.923

Review 8.  Cell-to-cell communication: microRNAs as hormones.

Authors:  Recep Bayraktar; Katrien Van Roosbroeck; George A Calin
Journal:  Mol Oncol       Date:  2017-10-26       Impact factor: 6.603

9.  Identification of a serum-induced transcriptional signature associated with metastatic cervical cancer.

Authors:  Anna Palatnik; Shuyun Ye; Christina Kendziorski; Marissa Iden; Jessica S Zigman; Martin J Hessner; Janet S Rader
Journal:  PLoS One       Date:  2017-08-30       Impact factor: 3.240

10.  Expression levels of serum miRNA-195 in different types of patients with cholangiocarcinoma and its value to determine the prognosis thereof.

Authors:  Qingliang Chen; Congmei Wang; Hongkai Zhang; Yun Li; Yunhong Cao; Yongxiang Zhang; Shaokun Liu; Zhen Li; Xiaoguo Xin; Xinwei Han
Journal:  Oncol Lett       Date:  2018-02-09       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.